March 2006
Drug Store News;3/6/2006, Vol. 28 Issue 3, p45
Trade Publication
The article reports on developments related to the pharmaceutical industry in the U.S. Perrigo Co. has received final approval to begin marketing over-the-counter nicotine polarcrilex lozenges. Adams Respiratory Therapeutics announced its plans to enter the pediatric market. Quigley Corp. partnered with Universal Pictures for a Cold-Eeze promotion.


Related Articles

  • Perrigo Company Awarded A Good Manufacturing Seal. Czurak, David // Grand Rapids Business Journal;4/22/2002, Vol. 20 Issue 16, pB8 

    Reports on The National Sanitary Foundation (NSF) International's awarding of its first Good Manufacturing Practices (GMP) registration to pharmaceuticals, vitamins and nutritional supplements manufacturer Perrigo Co. Functions of NSF; Role of the NSF GMP in validating the standards of a...

  • Product Recall, Flu Season Impact Perrigo Results. Emrich, Anne Bond // Grand Rapids Business Journal;2/7/2005, Vol. 23 Issue 6, p6 

    Discusses the financial performance of Perrigo Co. of Allegan, Michigan for the second quarter of fiscal 2005. Increase in net sales; Effect of the company's retail level recall of loratadine syrup on sales; Growth in the core vitamin product category of the company.

  • Perrigo rejects new Mylan bid. Investor's Business Daily // Investors Business Daily;4/30/2015, pA02 

    The article reports that drugstore supplier Perrigo Co. PLC has rejected the bid offered by American generic-drug maker Mylan NV following speculations that the bid would be bought by pharmaceutical company Teva Pharmaceutical Industries Ltd.

  • Pharma: Other News To Note.  // BioWorld Today;1/ 2/2013, Vol. 24 Issue 1, p4 

    The article reports on the merger agreement signed by Perrigo Co. of Allen, Michigan to acquire Chicago, Illinois-based Cobrek Pharmaceuticals Inc. for $45 million.

  • Mylan. Investor's Business Daily // Investors Business Daily;7/30/2015, pA02 

    The article reports on the announcement of pharmaceutical firm Mylan NV that it has received approval from regulations in Europe to push through with its proposal to aquire healthcare supplier Perrigo Co. PLC.

  • Generic Drugmakers Garner M&A Interest. Collins, Allison; Diakantonis, Demitri // Mergers & Acquisitions: The Dealermaker's Journal;Jan2016, Vol. 51 Issue 1, p8 

    The article reports on the active participation of dealmakers in the generic drug-making industry, which underscored by the merger and acquisition (M&A) activity from Perrigo Co. PLC, Cardinal Health Inc., Mylan NV, and Teva.

  • Drugmaker Drama Ends Without Hitch: Perrigo Shareholders Rebuff Mylan Bid. AMY REEVES // Investors Business Daily;11/13/2015, p00 

    The article reports that Perrigo Co. PLC's shareholders have opposed a hostile takeover bid by generic-drug manufacturer Mylan NV, resulting to the decline of Perrigo stock and an increase in Mylan stock. It reveals that Mylan stock posted a 12.9% increase while Perrigo stock has dropped by 6.2%...

  • Editors' Picks.  // Drug Store News;7/17/2006, Vol. 28 Issue 9, p10 

    The article presents a list of products launched by pharmaceutical companies at the National Association of Chain Drug Stores Marketplace conference in the U.S. Adams Respiratory Therapeutics Inc. has launched a pediatric Mucinex line. Novartis AG introduced a Theraflu liquid offering warming...

  • Pharma Shows Signs of Life. Goldstein, Scott // njbiz;6/26/2006, Vol. 19 Issue 26, p3 

    Presents an update on the status of the pharmaceutical and medical device industry in New Jersey, as of June 26, 2006. Level of an increase in investments in research in 2005; Companies that have moved to New Jersey and became members of the HealthCare Institute in 2005, including Adams...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics